Zwacka RM - Search Results

1

The enigmatic roles of caspases in tumor development.

Jäger R, Zwacka RM. Jäger R, et al. Among authors: zwacka rm. Cancers (Basel). 2010 Nov 24;2(4):1952-79. doi: 10.3390/cancers2041952. Cancers (Basel). 2010. PMID: 24281211 Free PMC article.

2

In situ trapping of initiator caspases reveals intermediate surprises.

Mohr A, Zwacka RM. Mohr A, et al. Among authors: zwacka rm. Cell Biol Int. 2007 May;31(5):526-30. doi: 10.1016/j.cellbi.2006.11.016. Epub 2006 Nov 28. Cell Biol Int. 2007. PMID: 17196842

3

IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells.

Büneker CK, Yu R, Deedigan L, Mohr A, Zwacka RM. Büneker CK, et al. Among authors: zwacka rm. Cancer Lett. 2012 Mar 28;316(2):168-77. doi: 10.1016/j.canlet.2011.10.035. Epub 2011 Nov 2. Cancer Lett. 2012. PMID: 22104728

4

A non-apoptotic role for caspase-9 in muscle differentiation.

Murray TV, McMahon JM, Howley BA, Stanley A, Ritter T, Mohr A, Zwacka R, Fearnhead HO. Murray TV, et al. J Cell Sci. 2008 Nov 15;121(Pt 22):3786-93. doi: 10.1242/jcs.024547. Epub 2008 Oct 28. J Cell Sci. 2008. PMID: 18957517

5

Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells.

Mohr A, Albarenque SM, Deedigan L, Yu R, Reidy M, Fulda S, Zwacka RM. Mohr A, et al. Among authors: zwacka rm. Stem Cells. 2010 Nov;28(11):2109-20. doi: 10.1002/stem.533. Stem Cells. 2010. PMID: 20882532

6

MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release.

Mohr A, Büneker C, Gough RP, Zwacka RM. Mohr A, et al. Among authors: zwacka rm. Oncogene. 2008 Jan 31;27(6):763-74. doi: 10.1038/sj.onc.1210673. Epub 2007 Jul 23. Oncogene. 2008. PMID: 17653087

7

Both human and mouse mesenchymal stem cells promote breast cancer metastasis.

Albarenque SM, Zwacka RM, Mohr A. Albarenque SM, et al. Among authors: zwacka rm. Stem Cell Res. 2011 Sep;7(2):163-71. doi: 10.1016/j.scr.2011.05.002. Epub 2011 May 10. Stem Cell Res. 2011. PMID: 21763624 Free article.

8

MSC.sTRAIL Has Better Efficacy than MSC.FL-TRAIL and in Combination with AKTi Blocks Pro-Metastatic Cytokine Production in Prostate Cancer Cells.

Mohr A, Chu T, Brooke GN, Zwacka RM. Mohr A, et al. Among authors: zwacka rm. Cancers (Basel). 2019 Apr 21;11(4):568. doi: 10.3390/cancers11040568. Cancers (Basel). 2019. PMID: 31010082 Free PMC article.

9

DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.

Yu R, Albarenque SM, Cool RH, Quax WJ, Mohr A, Zwacka RM. Yu R, et al. Among authors: zwacka rm. Cancer Biol Ther. 2014;15(12):1658-66. doi: 10.4161/15384047.2014.972183. Cancer Biol Ther. 2014. PMID: 25482930 Free PMC article.

10

Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model.

Mohr A, Lyons M, Deedigan L, Harte T, Shaw G, Howard L, Barry F, O'Brien T, Zwacka R. Mohr A, et al. J Cell Mol Med. 2008 Dec;12(6B):2628-43. doi: 10.1111/j.1582-4934.2008.00317.x. Epub 2008 Mar 28. J Cell Mol Med. 2008. PMID: 18373740 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page